These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36634997)

  • 21. Calcium ions, drug action and the heart--with special reference to calcium antagonist drugs.
    Opie LH
    Pharmacol Ther; 1984; 25(3):271-95. PubMed ID: 6151199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.
    Massie BM; Lacourcière Y; Viskoper R; Woittiez A; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):27C-33C. PubMed ID: 9286851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Use of Calcium Channel Blockers in the Treatment of Coronary Spasm and Atrioventricular Block.
    Gao B; Zhang Z; Qian J; Cao C; Hua X; Chu M; He X; Zeng H
    Cell Biochem Biophys; 2015 Jun; 72(2):527-31. PubMed ID: 25572060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of amlodipine in myocardial ischaemia.
    Taylor SH
    Postgrad Med J; 1991; 67 Suppl 5():S48-51. PubMed ID: 1839440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
    Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
    Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of calcium channel blockers and beta blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. The Netherlands Working Group on Cardiovascular Research (WCN).
    van der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Angiology; 1999 Jun; 50(6):447-54. PubMed ID: 10378820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of sarpogrelate and high-dose statin on the reduction of coronary spasm in vasospastic angina: A two by two factorial, pilot randomized study.
    Kim SR; Choi KH; Song YB; Lee JM; Park TK; Yang JH; Hahn JY; Choi JH; Choi SH; Gwon HC
    Clin Cardiol; 2019 Oct; 42(10):899-907. PubMed ID: 31339594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of chronic nitrate therapy in patients with vasospastic angina: multicentre registry study of the Japanese coronary spasm association.
    Takahashi J; Nihei T; Takagi Y; Miyata S; Odaka Y; Tsunoda R; Seki A; Sumiyoshi T; Matsui M; Goto T; Tanabe Y; Sueda S; Momomura S; Yasuda S; Ogawa H; Shimokawa H;
    Eur Heart J; 2015 Jan; 36(4):228-37. PubMed ID: 25189599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized, double-blind comparison of the efficacy and tolerability of once-daily modified-release diltiazem capsules with once-daily amlodipine tablets in patients with stable angina.
    Chugh SK; Digpal K; Hutchinson T; McDonald CJ; Miller AJ; Lahiri A
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):356-64. PubMed ID: 11486240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mibefradil in the treatment of chronic stable angina pectoris: comparative studies with other calcium antagonists.
    Davies GJ; Tzivoni D; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):34C-39C. PubMed ID: 9286852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of once-daily amlodipine versus twice-daily diltiazem controlled release (CR) in the treatment of stable angina pectoris. Amlodipine Study Group.
    van Kesteren HA; Withagen AJ
    Cardiovasc Drugs Ther; 1998 Oct; 12 Suppl 3():233-7. PubMed ID: 9800052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of amlodipine in stable effort angina. Comparison with diltiazem in terms of efficacy, tolerability and maintenance of the anti-ischemic action 24 hours after the last dose].
    Marchand X; Tibi T; Bernaud C; Morand P
    Ann Cardiol Angeiol (Paris); 1996 Feb; 45(2):74-82. PubMed ID: 8734139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paralytic ileus induced by the combined use of nifedipine and diltiazem in the treatment of vasospastic angina.
    Harada T; Ohtaki E; Sumiyoshi T; Hosoda S
    Cardiology; 2002; 97(2):113-4. PubMed ID: 11978960
    [No Abstract]   [Full Text] [Related]  

  • 34. Combination of calcium channel blockers and beta-blockers for patients with exercise-induced angina pectoris: beneficial effect of calcium channel blockers largely determined by their effect on heart rate.
    Cleophas TJ; van der Sluijs J; van der Vring JA; Daniëls MC; Holwerda KJ; Withagen AJ; Schelling A; Hendriks MG; Zwinderman AH
    J Clin Pharmacol; 1999 Jul; 39(7):738-46. PubMed ID: 10392329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential properties of mibefradil in hypertension and angina.
    Kobrin I
    J Hypertens Suppl; 1997 Dec; 15(5):S33-40. PubMed ID: 9481614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of cilostazol on uncontrolled coronary vasospastic angina: a pilot study.
    Yoo SY; Song SG; Lee JH; Shin ES; Kim JS; Park YH; Kim J; Chun KJ; Kim JH
    Cardiovasc Ther; 2013 Jun; 31(3):179-85. PubMed ID: 22953758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium antagonists.
    Conti CR; Pepine CJ; Feldman RL; Hill JA
    Cardiology; 1985; 72(5-6):297-321. PubMed ID: 2866840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of calcium antagonists in the treatment of myocardial ischemia.
    Follath F
    Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amlodipine once a day in stable angina: double-blind crossover comparison with placebo.
    Deedwania PC; Cheitlin MD; Das SK; Pool PE; Singh JB; Pasternak RC
    Clin Cardiol; 1993 Aug; 16(8):599-602. PubMed ID: 8370191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of calcium channel blockers and beta-adrenoceptor blockers for patients with exercise-induced angina pectoris: a double-blind parallel-group comparison of different classes of calcium channel blockers. Netherlands Working Group on Cardiovascular Research (WCN).
    Van Der Vring JA; Daniëls MC; Holwerda NJ; Withagen PJ; Schelling A; Cleophas TJ; Hendriks MG
    Br J Clin Pharmacol; 1999 May; 47(5):493-8. PubMed ID: 10336572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.